Effect of toxicity-adjusted dose (TAD) of sunitinib on intra-patient variation of trough levels: A longitudinal study in metastatic renal cell cancer (mRCC).
Alison Yan Zhang
No relevant relationships to disclose
Peter Fox
No relevant relationships to disclose
Sally Coulter
No relevant relationships to disclose
Bavanthi Balakrishnar
No relevant relationships to disclose
Christopher Liddle
No relevant relationships to disclose
Howard Gurney
No relevant relationships to disclose